After Hours Summary: GPS +8% on positive holiday sales, AMGN +4% and SNY -4% following Praluent injunction rulingAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance/SSS: GPS +8.1% (December comps of +3% vs -5% year ago and -1% (BR +5%, ON -2%) last month; now expect full-year EPS to be modestly above high end of previous guidance range), HELE +4.1%, AEHR +3.5%, RNVA +2.6% (discloses an FY17 outlook; expects to begin generating sales from the clinical research organization relationship in the first half of 2017; discloses on Dec 29 co filed a Certificate of Designation with the Secretary of State of Delaware to authorize the issuance of up to 1.75 mln shares of Series F convertible preferred stock), PSMT +0.7%
Companies trading higher in after hours in reaction to news: OGXI +62.1% (will acquire privately held Achieve Life Science in an all-stock transaction; co will be renamed 'Achieve Life Sciences' following completion of merger), STML +32.2% (announces positive FDA meeting and agreement on expedited pathway to full approval of SL-401 in first-line BPDCN), QTNT +18.7% (Quotient Limited reports positive MosaiQ results from performance evaluation study for blood grouping), MDCO +9.8% (attributed to Amgen / Sanofi cholesterol drug injunction decision), NBIX +6.7% (provides update on FDA advisory committee for Ingrezza for the treatment of tardive dyskinesia; FDA decided to cancel the Psychopharmacologic Drugs Advisory Committee meeting which was originally scheduled for Feb 16, 2017), MNTA +6.5% (enters into a research collaboration and worldwide license agreement w/ CSL to develop and commercialize Fc multimer proteins; co to receive $50 million upfront license fee and up to $550 million in potential milestone payments from CSL), URRE +4.7% (light volume; closed the sale of its Churchrock and Crownpoint properties in New Mexico to Laramide Resources for consideration valued at $12.5 mln), AMGN +4.4% (following cholesterol drug Praluent ruling), ANW +3.3% (light volume- launches new service center in Germany that will serve all German Baltic Sea ports and Southern Scandinavian ports; will acquire OBAST's existing share capital), BOX +3% (higher in after hours following CEO appearance on CNBC -- discussed Facebook partnership), ILMN +2.6% (announced that GRAIL has received indications of interest to invest approximately $1B for its Series B financing primarily from undisclosed private and strategic investors; ILMN is invested in GRAIL), EXPE +0.5% (upgraded to Buy at Stifel)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: RT -15.3%, GIII -8.4% (lowers FY17 guidance due to warm weather, persistant lower traffic and challenging retail environment), SHAK -1.7% (appoints Zach Koff as COO and announces CFO Jeff Uttz will retire in 2017; remain confident in the 2016 financial guidance ranges), SUM -1.7% (reports downside Q4 prelim results; launches offering of 10,000,000 shares of its Class A common stock), FC -1.5%, AMRN -1.3% (light volume - sees FY17 revs $155-165 mln vs $171.30 mln Capital IQ Consensus Estimate; sees FY16 rev exceeding prior range)
Companies trading lower in after hours in reaction to news: UEC -10.8% (files for $100 mln mixed securities shelf offering), SNY -4.2% (following cholesterol drug Praluent ruling), GNK -4% (ticking lower; files for 27,061,856 share common stock offering by selling shareholders that were issued upon the conversion of the Series A Preferred Stock), P -2.9% (following Sirius XM Radio CFO conference commentary - ultimately dismissing the possibility of M&A deal), MYOK -2.8% (files for $250 mln mixed securities shelf offering), FRSH -2.2% (CEO resigns; Chair of the Board, Jean Birch, has been appointed interim CEO), MRTX -1.7% (ticking lower - announced data from two ongoing clinical programs including the Phase 1b and Phase 2 trials of glesatinib; announces that co intends to offer and sell shares of its common stock)